| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238039.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.002345582 |
Resistant |
| ENSG00000238039.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047220543 |
Resistant |
| ENSG00000238039.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018203483 |
Resistant |
